Uterine Manipulation Devices Market

Global Uterine Manipulation Devices Market – Overview

The rising prevalence of diseases related to female reproductive organs, increase in the adoption of minimally invasive or noninvasive procedures, and technological advancements are among the major factors driving the market. The market has been adversely impacted by the pandemic. The COVID-19 pandemic is affecting significant aspects of various companies, such as product demand, operations, supply chain, distribution systems, and the ability to research and develop new products. Almost all the companies are affected by reduced procedure volume due to COVID-19 as all hospital resources are being diverted to combat the disease.

Global Uterine Manipulation Devices Market – Notable Developments

• In February 2021, CooperSurgical Inc. acquired AEGEA Medical. The acquisition is expected to help the company expand its product portfolio of women's healthcare.
• In another instance, in October 2020, LABORIE Medical Technologies partnered with Urotronic. The partnership would expand the use of minimally invasive treatments and advance outcomes for patients suffering from urological disorders.
• In May 2020, Minerva Surgical, Inc. acquired the Intrauterine Health Products segment from Boston Scientific Corporation. The products include Resectr Tissue Resection Device; Symphion Tissue Removal System; and the Genesys HTA System, which are used for the treatment of abnormal uterine bleeding.
• In 2020, the total laparoscopic hysterectomy (TLH) segment dominated the market with a revenue share of 38.88%. TLH is performed for treating conditions such as fibroids, pelvic pain, painful or heavy menstrual periods, pre-cancer or cancer in the uterus, endometriosis or adenomyosis, or prolapse

Some prominent players in the global uterine manipulation devices market include Conkin Surgical Instruments Ltd., Johnson and Johnson, CooperSurgical, Inc., B. Braun Medical Ltd., KARL STORZ GmbH & Co. KG, CONMED Corporation, RUDOLF Medical GmbH + Co. KG, LiNA Medical ApS, Richard Wolf GmbH, Utah Medical Products, Inc., Purple Surgical, Clinical Innovations, LLC, Bissinger Medizintechnik, The O.R. Company (Symmetry Surgical Inc.), LSI Solutions, Inc.,

Global Uterine Manipulation Devices Market – Drivers and Restraints

Health information exchange solutions have a few helpful applications in healthcare. In any case, the reception of these solutions is limited to a degree attributable to data security and privacy concerns. Patient health data is secured under government laws in numerous nations, and any breaks or failure to keep up with its honesty can result in legitimate and monetary punishments. Patient data contains individual, private, or secret information and requires severe defending to forestall its abuse. Since the interoperable solutions utilized for patient care expect admittance to numerous health data sets, it is fundamental for these solutions to cling to every one of the data security conventions executed by states and administrative authorities. This is a troublesome undertaking as most interoperability stages are merged and require broad figuring power, inferable from which patient data, or portions of it, can be needed to dwell in a merchant's data place.

Global Uterine Manipulation Devices Market – Geographical Outlook

Based on the regional segmentation, the global Health information exchange (HIE) market can be segmented into five key regions. These regional segments are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of these, the global Health information exchange (HIE) market is expected to be dominated by the regional segment of North America. The growth of the North America market can be primarily attributed to the increasing demand for information exchange from the global healthcare industry. North America dominated the market with a considershare of 35.67% in 2020 and is expected to witness considerable growth over the forecast period. This is owing to the increasing number of gynecology-related surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and supportive regulatory reforms in the healthcare sector.